EXECERATE
Live / Registered — Registered — Section 71 accepted (as of 27 Feb 2025)
What this means for you
Registered since 15 Aug 2017. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (the §71 ten-year affidavit of use is due by 15 Aug 2027, and its filing window is open now).
Record
- Serial number
- 79204653
- Registration number
- 5263113
- Mark type
- Word mark
- Filed
- 18 Dec 2016
- Published for opposition
- 30 May 2017
- Registered
- 15 Aug 2017
- Next maintenance filing
- §71 ten-year affidavit of use, due by 15 Aug 2027 (grace period to 15 Feb 2028)
- Attorney of record
- Jason M. Vogel
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treatment and prevention of liver diseases, cancer, hepatitis, and non-alcoholic fatty liver syndrome
Owner
- Can-Fite Biopharma Ltd, Petah Tikva, IL
- Can-Fite Biopharma Ltd, Petah Tikva, IL
- Can-Fite Biopharma Ltd, Petah Tikva, IL
Prosecution history
- 15 Aug 2026 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
- 27 Feb 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
- 27 Feb 2025 — REGISTERED-SEC.71 ACCEPTED
- 01 Nov 2024 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 20 Aug 2024 — POST REGISTRATION ACTION MAILED - SEC.71
- 16 Apr 2024 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Aug 2023 — TEAS SECTION 71 RECEIVED
- 06 Feb 2023 — NEW REPRESENTATIVE AT IB RECEIVED
- 19 Feb 2021 — NEW REPRESENTATIVE AT IB RECEIVED
- 06 Oct 2017 — NOTIFICATION PROCESSED BY IB
- 21 Sept 2017 — FINAL DISPOSITION NOTICE SENT TO IB
- 21 Sept 2017 — FINAL DISPOSITION PROCESSED
- 14 Sept 2017 — GRANT OF PROTECTION CREATED, TO BE SENT TO IB
- 15 Aug 2017 — REGISTERED-PRINCIPAL REGISTER
- 30 May 2017 — PUBLISHED FOR OPPOSITION